A preliminary analysis of the effects of elliptinium on immune reactivities in mice
- 30 June 1986
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (6) , 637-645
- https://doi.org/10.1016/0277-5379(86)90160-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cancer chemotherapeutics as immunomodulatorsSpringer Seminars in Immunopathology, 1985
- Natural Killer Cells: Their Roles in Defenses Against DiseaseScience, 1981
- Antitumor Activity, Pharmacology, and Toxicity of Ellipticines, Ellipticinium, and 9-Hydroxy Derivatives: Preliminary Clinical Trials of 2-Methyl-9-Hydroxy Ellipticinium (NSC 264-137)Published by Springer Nature ,1980
- Comparative cytotoxic and antitumoral effects of ellipticine derivatives on mouse L 1210 leukemiaChemico-Biological Interactions, 1979
- The Role of Adherent Cells in B and T Lymphocyte ActivationImmunological Reviews, 1978
- Tumor cell killing by macrophages activated in vitro with lymphocyte mediatorsCellular Immunology, 1978
- Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264-137) in advanced human cancersPublished by Elsevier ,1978
- THE IMMUNODEPRESSIVE AND HEMATOTOXIC ACTIVITY OF IMIDAZOLE-4-CARBOXAMIDE,5-(3,3-DIMETHYL-1-TRIAZENO) IN MICETransplantation, 1976
- In vitro inhibition of tumour cell growth and DNA synthesis by peritoneal and lung macrophages from mice injected withcorynebacterium parvumInternational Journal of Cancer, 1974